Skip to main content
Premium Trial:

Request an Annual Quote

staff reporter

Articles Authored by staff reporter

May 31, 2023

Coave Therapeutics Preparing for Retinitis Pigmentosa Gene Therapy Registration Trial

May 31, 2023

Precigen to Begin Phase II Study of PRGN-2009, Keytruda in HPV-Positive Cervical Cancer

May 31, 2023

RayzeBio Advances RYZ101 to Phase III Study in SSTR-Positive Neuroendocrine Tumors

May 31, 2023

Yuhan Licenses HER2 Inhibitor From J INTS Bio in $325M Deal

May 30, 2023

Anew Medical Expecting to Access $54M Following SPAC Merger

May 30, 2023

FDA Reviewing Iovance's BLA for Melanoma TIL Therapy; Decision Expected in November

May 30, 2023

FDA Accepts BMS's NDA for Repotrectinib in ROS1-Positive NSCLC

May 30, 2023

FDA Approves Blue Earth Diagnostics' PSMA-Targeted Radiohybrid PET Imaging Agent

May 30, 2023

Cepheid Nabs CE-IVD Mark for Molecular NPM1 Mutation Test for AML Monitoring